| Literature DB >> 30767423 |
Jing Wang1, Ya-Yun Zuo1, Ling-Li Li1, Hui Wang1, Shao-Yan Liu1, Yi-Hua Yang1, Yi-Dong Wu1.
Abstract
Bacillus thuringiensis (Bt) insecticidal toxins have been globally utilized for control of agricultural insects through spraying or transgenic crops. Binding of Bt toxins to special receptors on midgut epithelial cells of target insects is a key step in the mode of action. Previous studies suggested aminopeptidase N1 (APN1) as a receptor or putative receptor in several lepidopteran insects including Helicoverpa armigera through evidence from RNA interefence-based gene silencing approaches. In the current study we tested the role of APNs in the mode of action of Bt toxins using clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated protein 9-mediated gene knockout. Three APN genes (HaAPN1, HaAPN2 and HaAPN5) were individually knocked out in a susceptible strain (SCD) of H. armigera to establish three homozygous knockout strains. Qualitative in vitro binding studies indicated binding of Cry1Ac or Cry2Ab to midgut brush border membrane vesicles was not obviously affected by APN knockout. Bioassay results showed that none of the three knockouts had significant changes in susceptibility to Cry1A or Cry2A toxins when compared with the SCD strain. This suggests that the three HaAPN genes we tested may not be critical in the mode of action of Cry1A or Cry2A toxins in H. armigera.Entities:
Keywords: Bacillus thuringiensis; CRISPR/Cas9; Helicoverpa armigera; aminopeptidase N; receptor
Mesh:
Substances:
Year: 2019 PMID: 30767423 PMCID: PMC7277041 DOI: 10.1111/1744-7917.12666
Source DB: PubMed Journal: Insect Sci ISSN: 1672-9609 Impact factor: 3.262
Oligonucleotide sequences for in vitro preparation of the single‐guide RNA (sgRNA) templates and polymerase chain reaction primers for genotyping indel mutations of HaAPNs
| Name | Sequence (5′–3′) |
|---|---|
| sgRNA‐APN1‐F | GAAATTAATACGACTCACTATAGGTTCATGGAAACTTCGCCTGTTTTAGAGCTAGAAATAGC |
| sgRNA‐APN2‐F | GAAATTAATACGACTCACTATAGGTCTGGAGTAGACCCTGAAGTTTTAGAGCTAGAAATAGC |
| sgRNA‐APN5‐F | GAAATTAATACGACTCACTATAGGACAATACGCTCTAGAAGTGTTTTAGAGCTAGAAATAGC |
| sgRNA‐R | AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC |
| HaAPN1‐F | TTCCACACCACTCCCGAAACAT |
| HaAPN1‐R | GTCAAAAGTCCCCAGTTCTCCA |
| HaAPN2‐F | CAAGATACCCTCATCATGTCCA |
| HaAPN2‐R | GCCACCTTATCCATCTTCGG |
| HaAPN5‐F | TCAGCCTACTTGGTAACCTTCC |
| HaAPN5‐R | CTGAAGCCCAATAAGGAGAAGC |
†The target sequences for each sgRNA are underlined.
Figure 1Schematic representation of an HaAPN (aminopeptidase N) protein of Helicoverpa armigera (A) and the positions and sequences targeted by single‐guide RNAs in HaAPN1, HaAPN2 and HaAPN5 (B). The cleavage sites of clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR‐associated protein 9 are indicated by red triangles.
The summary of genotyping data during the generation of HaAPN knockout strains
| Genotype (G1) | ||||||
|---|---|---|---|---|---|---|
| Target gene | Hatching rate (G0) | Editing rate (G0) | MM | MW | WW | Homozygote frequency (G2) |
|
| 57.2% (95/166) | 62.0% (31/50) | 0 | 17 | 18 | 20.8% (20/96) |
|
| 37.1% (78/210) | 96.6% (56/58) | 53 | 44 | 39 | 11.5% (11/96) |
|
| 40.5% (81/200) | 88.9% (48/54) | 68 | 29 | 34 | 12.9% (9/70) |
†Hatching rate = neonates / eggs injected.
‡Editing rate = moths edited / moths detected.
§MM: both APN alleles were mutated. MW: one APN allele was mutated and the other is the wild type. WW: both APN alleles were the wild type.
¶Homozygote frequency = homozygous mutants / pupae genotyped. HaAPN1 mutation: 5‐bp deletion in exon 4; HaAPN2 mutation: 1‐bp insertion in exon 3; HaAPN5: 1‐bp deletion in exon 4.
Figure 2The clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR‐associated protein 9 induced mutation types of the target HaAPN genes in G0. The target sequences of the wild type allele of each gene are highlighted in yellow and the protospacer adjacent motif (PAM) sequences in green. The cleavage site is shown as a red triangle. Deleted bases are represented by dashes and inserted bases are shown in lower case. The underlined mutation types for each HaAPN were subsequently selected to establish homozygous knockout strains.
Figure 3Qualitative binding of Cry1Ac and Cry2Ab to midgut brush border membrane vesicles (BBMVs). BBMVs from each strain were incubated with Cry1Ac or Cry2Ab, then pelleted by centrifugation. Bound toxins to pelleted BBMVs were separated by sodium dodecyl sulfate – polyacrylamide gel electrophoresis, blotted onto polyvinylidene difluoride membrane, and detected by either Cry1Ac or Cry2Ab antibodies. A single band of 65 kDa was observed for activated Cry1Ac, and two bands (60 kDa and 48 kDa) for activated Cry2Ab.
Toxicological responses to Cry1A and Cry2A toxins in the wild‐type SCD strain and three knockouts of Helicoverpa armigera
| Toxin | Strain |
| Slope ± SE | LC50 (95% FL | TR |
|---|---|---|---|---|---|
| Cry1Aa | SCD | 384 | 1.7 ± 0.18 | 0.19 (0.15–0.24) | |
| SCD‐APN1 | 384 | 1.7 ± 0.16 | 0.17 (0.13–0.21) | 0.9 | |
| SCD‐APN2 | 384 | 1.7 ± 0.16 | 0.16 (0.13–0.20) | 0.8 | |
| SCD‐APN5 | 384 | 1.7 ± 0.16 | 0.23 (0.19–0.29) | 1.2 | |
| Cry1Ab | SCD | 384 | 2.1 ± 0.28 | 0.043 (0.019–0.073) | |
| SCD‐APN1 | 384 | 1.9 ± 0.18 | 0.035 (0.028–0.043) | 0.8 | |
| SCD‐APN2 | 384 | 1.7 ± 0.16 | 0.028 (0.019–0.039) | 0.7 | |
| SCD‐APN5 | 384 | 2.2 ± 0.20 | 0.041 (0.034–0.050) | 1.0 | |
| Cry1Ac | SCD | 384 | 1.9 ± 0.26 | 0.0038 (0.0030–0.0050) | |
| SCD‐APN1 | 384 | 1.9 ± 0.18 | 0.0037 (0.0030–0.0045) | 1.0 | |
| SCD‐APN2 | 384 | 2.0 ± 0.19 | 0.0038 (0.0031–0.0046) | 1.0 | |
| SCD‐APN5 | 384 | 1.9 ± 0.18 | 0.0034 (0.0028–0.0042) | 0.9 | |
| Cry2Aa | SCD | 384 | 2.8 ± 0.35 | 0.42 (0.35–0.50) | |
| SCD‐APN1 | 384 | 1.6 ± 0.15 | 0.27 (0.19–0.40) | 0.6 | |
| SCD‐APN2 | 384 | 1.7 ± 0.16 | 0.29 (0.23–0.36) | 0.7 | |
| SCD‐APN5 | 384 | 1.4 ± 0.14 | 0.30 (0.23–0.39) | 0.7 | |
| Cry2Ab | SCD | 384 | 2.0 ± 0.24 | 0.49 (0.39–0.62) | |
| SCD‐APN1 | 384 | 1.7 ± 0.16 | 0.32 (0.26–0.40) | 0.7 | |
| SCD‐APN2 | 384 | 2.0 ± 0.18 | 0.38 (0.31–0.46) | 0.8 | |
| SCD‐APN5 | 384 | 1.6 ± 0.15 | 0.32 (0.25–0.40) | 0.7 |
†Number of insects tested.
‡95% fiducial limits.
§Toxicity ratio = LC50 of the knockouts divided by LC50 of SCD.
LC50, concentration of toxin killing 50% of larvae.